AstraZeneca (UK)

AstraZeneca is one of the world's leading pharmaceutical companies, and the #2 British company in the market behind GlaxoSmithKline. It has a strong current portfolio which includes 11 products with sales of over $1bn, led by the gastrointestinal drug Nexium. However the company's future drugs pipeline was weakened considerably in the early 2000s by patent expiries and the failure of several planned products. In 2007, the group agreed to acquire US biotechnology developer MedImmune. Based in the UK, AstraZeneca's R&D HQ is in Sweden and the company also has a strong presence in the key US market. Click here to access the Adbrands profile (subscribers only); or subscribe to Adbrands.net here. Adbrands Company Profiles provide a detailed analysis of the history and current operations of leading advertisers, agencies and brands worldwide, and include a critical summary which identifies key strengths and weaknesses. Adbrands Account Assignments tracks account management for the world's leading brands and companies, including details of which advertising agency handles which accounts in which countries for major markets.

Advertising: Which agencies handle advertising for AstraZeneca? The searchable account assignments database is available to full subscribers to Adbrands.net premium services. Click here for subscription information.

Competitors: see Pharmaceutical Sector index for other companies

Subscribers may access the following website links:

AstraZeneca website

Losec / Prilosec	Toprol XL
Nexium	Seroquel
Zestril	Nolvadex
Pulmicort	Arimidex
Iressa	Atacand
Symbicort	Diprivan
Casodex	Zoladex
Zomig	Astra Tech
MedImmune	Crestor

AstraZeneca worldwide

Click HERE to subscribe to Adbrands.net and access the profile and website links